02380 408 600 Contact us
Menu
×

Publications

  • Publication Subject

  • Filter by Author

Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study

  • Author

    Brian Chun-Fai-Chan Gideon Koren Ibrahim Fayez Sanjog Kalra Sharon Voyer-Lavigne Andrew Boshier Saad Shakir Adrienne Einarson

    Brian Chun-Fai-Chan, Gideon Koren, Ibrahim Fayez, Sanjog Kalra, Sharon Voyer-Lavigne, Andrew Boshier, Saad Shakir, Adrienne Einarson

  • Cite

    Am J Obstet Gynecol. 2005 Mar;192(3):932-6

View Publication

Hospital admissions for ‘drug-induced’ disorders in England: a study using the Hospital Episodes Statistics (HES) database

  • Author

    Patrick Waller Mary Shaw Davidson Ho Saad Shakir Shah Ebrahim

    Patrick Waller, Mary Shaw, Davidson Ho, Saad Shakir, Shah Ebrahim

  • Cite

    Br J Clin Pharmacol. 2005 Feb;59(2):213-9

View Publication

Relative risk of vaginal candidiasis after use of antibiotics compared with antidepressants in women (multiple letters)

  • Author

    Richard Elliott

    Richard Elliott

  • Cite

    Drug Saf. 2005;28(6):557; author reply 558

View Publication

Observational cohort study to monitor the use and safety of carvedilol in the treatment of heart failure in clinical practice in England–1st interim report

  • Author

    N V Acharya L V Wilton S A W Shakir

    Nayan Acharya, Lynda Wilton, Saad Shakir

  • Cite

    Int J Clin Pharmacol Ther. 2005 Jan;43(1):1-6

View Publication

A comparison of reported gastrointestinal and thromboembolic events between rofecoxib and celecoxib using observational data

  • Author

    N V Acharya L V Wilton S A W Shakir

    Nayan Acharya, Lynda Wilton, Saad Shakir

  • Cite

    Drug Saf. 2005;28(9):803-16

View Publication

Safety profile of celecoxib as used in general practice in England: results of a prescription-event monitoring study

  • Author

    Deborah Layton Lynda V Wilton Saad A W Shakir

    Deborah Layton, Lynda Wilton, Saad Shakir

  • Cite

    Eur J Clin Pharmacol. 2004 Sep;60(7):489-501

View Publication

Evaluation of the safety of sildenafil for male erectile dysfunction: experience gained in general practice use in England in 1999

  • Author

    A Boshier L V Wilton S A W Shakir

    Andrew Boshier, Lynda Wilton, Saad Shakir

  • Cite

    BJU Int. 2004 Apr;93(6):796-801

View Publication

Identification and evaluation of a possible signal of exacerbation of colitis during rofecoxib treatment, using Prescription-Event Monitoring data

  • Author

    D Layton E Heeley S A W Shakir

    Deborah Layton, Emma Heeley, Saad Shakir

  • Cite

    J Clin Pharm Ther. 2004 Apr;29(2):171-81

View Publication

Prescription-Event Monitoring (PEM) Study of Sildenafil in England.

  • Author

    Shakir SAW Boshier A

    Saad Shakir, Andrew Boshier

  • Cite

    Am J Urol Review. January 2004

View Publication

Yellow Card and ‘green form’ reporting: when is it necessary?

  • Author

    Shakir SAW Layton D

    Saad Shakir, Deborah Layton

  • Cite

    Supplementary Prescribing in Practice. January 2004

View Publication

Do some inhibitors of COX-2 increase the risk of thromboembolic events?: Linking pharmacology with pharmacoepidemiology

  • Author

    David W J Clark Deborah Layton Saad A W Shakir

    David Clark, Deborah Layton, Saad Shakir

  • Cite

    Drug Saf. 2004;27(7):427-56

View Publication

Causality and Correlation in Pharmacovigilance

  • Author

    Shakir SAW

    Saad Shakir

  • Cite

    Stephens' Detection of New Adverse Drug Reactions. January 2004

View Publication

Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practice use in England in 2000

  • Author

    Andrew Boshier Lynda V Wilton Saad A W Shakir

    Andrew Boshier, Lynda Wilton, Saad Shakir

  • Cite

    Eur J Clin Pharmacol. 2003 Dec;59(10):767-73

View Publication

Comparison of the incidence rates of thromboembolic events reported for patients prescribed celecoxib and meloxicam in general practice in England using Prescription-Event Monitoring (PEM) data

  • Author

    Deborah Layton Kerry Hughes Scott Harris Saad A W Shakir

    Deborah Layton, Kerry Hughes, Scott Harris, Saad Shakir

  • Cite

    Rheumatology (Oxford). 2003 Nov;42(11):1354-64

View Publication

Comparison of the incidence rates of thromboembolic events reported for patients prescribed rofecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data

  • Author

    D Layton E Heeley K Hughes S A W Shakir

    Deborah Layton, Emma Heeley, Kerry Hughes, Saad Shakir

  • Cite

    Rheumatology (Oxford). 2003 Nov;42(11):1342-53.

View Publication

Pharmacovigilance study of alendronate in England

  • Author

    Pipasha N Biswas Lynda V Wilton Saad A W Shakir

    Pipasha Biswas, Lynda Wilton, Saad Shakir

  • Cite

    Osteoporos Int. 2003 Jul;14(6):507-14

View Publication

Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed rofecoxib and meloxicam in general practice in England using prescription-event monitoring data

  • Author

    D Layton E Heeley K Hughes S A W Shakir

    Deborah Layton, Emma Heeley, Kerry Hughes, Saad Shakir

  • Cite

    Rheumatology (Oxford). 2003 May;42(5):622-31

View Publication

The pharmacovigilance of mirtazapine: results of a prescription event monitoring study on 13554 patients in England

  • Author

    Pipasha N Biswas Lynda V Wilton Saad A W Shakir

    Pipasha Biswas, Lynda Wilton, Saad Shakir

  • Cite

    J Psychopharmacol. 2003 Mar;17(1):121-6

View Publication

Safety profile of rofecoxib as used in general practice in England: results of a prescription-event monitoring study

  • Author

    Deborah Layton Jane Riley Lynda V Wilton Saad A W Shakir

    Deborah Layton, Jane Riley, Lynda Wilton, Saad Shakir

  • Cite

    Br J Clin Pharmacol. 2003 Feb;55(2):166-74

View Publication

Prospective observational cohort safety study to monitor the introduction of a non-CFC formulation of salbutamol with HFA134a in England

  • Author

    P M Craig-McFeely L V Wilton J B Soriano W C Maier S A W Shakir

    Patrick Craig-McFeely, Lynda Wilton, Joan Soriano, Will Maier, Saad Shakir

  • Cite

    Int J Clin Pharmacol Ther. 2003 Feb;41(2):67-76

View Publication

Prolongation of the QT interval and cardiac arrhythmias associated with cisapride: limitations of the pharmacoepidemiological studies conducted and proposals for the future

  • Author

    Deborah Layton Cheryl Key Saad A W Shakir

    Deborah Layton, Cheryl Key, Saad Shakir

  • Cite

    Pharmacoepidemiol Drug Saf. 2003 Jan-Feb;12(1):31-40

View Publication

The pharmacovigilance of pantoprazole: the results of postmarketing surveillance on 11 541 patients in England

  • Author

    Lynda V Wilton Cheryl Key Saad A W Shakir

    Lynda Wilton, Cheryl Key, Saad Shakir

  • Cite

    Drug Saf. 2003;26(2):121-32

View Publication

Relative risk of vaginal candidiasis after use of antibiotics compared with antidepressants in women: postmarketing surveillance data in England

  • Author

    Lynda Wilton Monika Kollarova Emma Heeley Saad Shakir

    Lynda Wilton, Monika Kollarova, Emma Heeley, Saad Shakir

  • Cite

    Drug Saf. 2003;26(8):589-97

View Publication

A postmarketing surveillance study of gabapentin as add-on therapy for 3,100 patients in England

  • Author

    Lynda V Wilton Saad Shakir

    Lynda Wilton, Saad Shakir

  • Cite

    Epilepsia. 2002 Sep;43(9):983-92

View Publication

Pharmacovigilance of over-the-counter products based in community pharmacy: methodological issues from pilot work conducted in Hampshire and Grampian, UK

  • Author

    D Layton H K Sinclair C M Bond P C Hannaford S A W Shakir

    Deborah Layton, Hazel Sinclair, Christine Bond, Philip Hannaford, Saad Shakir

  • Cite

    Pharmacoepidemiol Drug Saf. 2002 Sep;11(6):503-13

View Publication